We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Teva Accused of Patent Infringement Over Hypothyroidism Treatment
Teva Accused of Patent Infringement Over Hypothyroidism Treatment
Teva Pharmaceuticals has been hit with a patent infringement suit in a Delaware district court by Switzerland-based Ibsa Pharmaceuticals and Altergon over its generic version of Ibsa’s hypothyroidism treatment Tirosint (levothyroxine).